Jonathan S Foot - JoVE Visualize

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Journal of Medicinal Chemistry|October 4, 2019

Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3Alison D Findlay, Jonathan S Foot, Alberto Buson, et al.

The Journal of Pharmacology and Experimental Therapeutics|August 15, 2013

PXS-4681A, a potent and selective mechanism-based inhibitor of SSAO/VAP-1 with anti-inflammatory effects in vivoJonathan S Foot, Tin T Yow, Heidi Schilter, et al.

Oncotarget|February 16, 2017

Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancerJoan Chang, Morghan C Lucas, Lidia E Leonte, et al.

Journal of Cellular and Molecular Medicine|December 12, 2018

The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosisHeidi Schilter, Alison D Findlay, Lara Perryman, et al.

Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Journal of Medicinal Chemistry|October 4, 2019

Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3Alison D Findlay, Jonathan S Foot, Alberto Buson, et al.

The Journal of Pharmacology and Experimental Therapeutics|August 15, 2013

PXS-4681A, a potent and selective mechanism-based inhibitor of SSAO/VAP-1 with anti-inflammatory effects in vivoJonathan S Foot, Tin T Yow, Heidi Schilter, et al.

Oncotarget|February 16, 2017

Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancerJoan Chang, Morghan C Lucas, Lidia E Leonte, et al.

Journal of Cellular and Molecular Medicine|December 12, 2018

The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosisHeidi Schilter, Alison D Findlay, Lara Perryman, et al.

Pageof 2